Mineracim + (capsules "Morning" and "Evening")

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.E.011822.07.12
Date of registration and renewal:20.07.2012
Dosage form: & nbspCapsules "Morning" and "Evening" for 400 mg ± 10%.
Classification "Composition" & nbsp Supplements - vitamins, vitamin-like substances and coenzymes Supplements - macro and microelements
Classification "Clinical" & nbsp Supplements containing zinc, copper, manganese Supplements containing iron Supplements containing iodine Supplements containing chromium Supplements containing selenium
Composition: & nbspThe composition of the capsule "Morning": potassium asparaginate, magnesium citrate, hawthorn extract, thallus fumarate extract, chromium picolinate, lactose.

The composition of the capsule "Evening": calcium carbonate, magnesium citrate, mineral premix 15-03 (iron, manganese, copper, zinc, selenium, iodine), bog wort extract, grass horsetail extract, lactose.
Scope: & nbspFor sale to the population through the pharmacy network and specialized shops, departments of the trade network as a biologically active food additive - a source of flavonoids and an additional source of mineral substances (manganese, iron, copper, zinc, chromium, selenium, iodine).
Suggested Usage: & nbspFor adults and children over 14 years, 1 capsule "Morning" in the morning, 1 capsule "Evening" in the afternoon with meals. Duration of admission is 4-6 weeks. If necessary, the reception can be repeated. Repeated receptions are possible throughout the year.
Contraindications:Individual intolerance of components, pregnancy, breast-feeding, people with thyroid disease is recommended to consult with an endocrinologist.
Shelf life:2 years.
Storage conditions:Store in a dry place, protected from light and out of reach of children, at a temperature of no higher than 25 ° C.
Research protocols:Expert conclusion of the FBUC of the Federal Target Program and the Federal Service for Consumer Rights Protection No. 10-2FTS / 2593 of 25.06.2012.
Recipient:National Research and Production Center, LLCNational Research and Production Center, LLC Russia
Information update date: & nbsp16.06.16
Instructions
Up
talkdrugs

+8 (800)555-35-35

[email protected]

The reference book of medicines of the Publishing Group "GEOTAR-Media" - the leader in the field of professional medical and pharmaceutical literature.

The information on the preparations placed on the site is intended only for specialists. Drug descriptions can not be used by patients to make an independent decision on their use.

It is forbidden to copy any instructions of medicines,biologically active additives or other information from the site www.talkdrugs.info without the written permission of the Publishing House "GEOTAR".

All rights reserved. © Publishing group "GEOTAR-Media" 2008-2016.